Pathstone Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pathstone Holdings’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.85M	Buy	11,683 +3,439	+42%	+$465K	0.01%	1150
2026 Q1	$1.05M	Buy	8,244 +1,170	+17%	+$146K	﹤0.01%	1383
2025 Q4	$863K	Buy	7,074 +2,239	+46%	+$257K	﹤0.01%	1490
2025 Q3	$484K	Hold	4,835	–	–	﹤0.01%	1787
2025 Q2	$401K	Sell	4,835 -526	-10%	-$42K	﹤0.01%	1811
2025 Q1	$435K	Buy	5,361 +699	+15%	+$62.5K	﹤0.01%	1780
2024 Q4	$418K	Buy	4,662 +118	+3%	+$11.4K	﹤0.01%	1807
2024 Q3	$449K	Buy	4,544 +207	+5%	+$20.3K	﹤0.01%	1784
2024 Q2	$402K	Sell	4,337 -1,844	-30%	-$165K	﹤0.01%	1803
2024 Q1	$587K	Buy	6,181 +1,916	+45%	+$178K	﹤0.01%	1604
2023 Q4	$381K	Buy	+4,265	New	+$317K	﹤0.01%	1672

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Pathstone Holdings's XBI Position: Q2 2026 in Review

Pathstone Holdings increased its State Street SPDR S&P Biotech ETF (XBI) stake by 42% in Q2 2026, buying an estimated $465K and bringing the position to 11,683 shares worth $1.85M. The position accounts for 0.01% of the portfolio, ranked #1150.

Pathstone Holdings first reported a position in XBI in Q4 2023 and has held it in 11 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Pathstone Holdings held 11,683 shares of State Street SPDR S&P Biotech ETF worth $1.85M as of Q2 2026.
Pathstone Holdings bought 3,439 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $465K.
State Street SPDR S&P Biotech ETF made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1150 holding.
Pathstone Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 11 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.